9999999997-15-012688.txt : 20150821 9999999997-15-012688.hdr.sgml : 20150821 20150821101148 ACCESSION NUMBER: 9999999997-15-012688 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20150821 DATE AS OF CHANGE: 20150821 20150821 20150821 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ZOGENIX, INC. CENTRAL INDEX KEY: 0001375151 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205300780 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-34962 FILM NUMBER: 151067868 BUSINESS ADDRESS: STREET 1: 12400 HIGH BLUFF DRIVE STREET 2: SUITE 650 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 259-1165 MAIL ADDRESS: STREET 1: 12400 HIGH BLUFF DRIVE STREET 2: SUITE 650 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: ZOGENIX INC DATE OF NAME CHANGE: 20060911 CT ORDER 1 filename1.pdf begin 644 filename1.pdf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